Internal Server Error

About Presight Capital

Presight Capital is a venture capital firm founded in 2019. It is primarily based out of West Hollywood, United States. As of Mar 2026, Presight Capital is an active investor, having invested in 39 companies, with 2 new investments in the last 12 months. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to FinTech and Retail. Most recently it participated in the $***** Series E round of Alloy Therapeutics Overall, Presight Capital portfolio has seen 2 unicorns, 2 IPOs and 4 acquisitions including key companies like Qonto, Abcellera Biologics and Razor Group. A lot of funds co-invest with Presight Capital, with names like 468 Capital sharing a substantial percentage of its portfolio. Presight Capital has team of 3 people including 1 partners.
Key Metrics
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 5 more
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months

Presight Capital's List of Top Investments

Presight Capital has a portfolio of 39 companies, including 2 unicorns. Their most notable investments are in Peptilogics and Valoreo.Their portfolio spans across United States, United Kingdom, India and 9 more locations. They have invested in Life Sciences, FinTech, Retail and 17 other sectors, across stages such as Seed, Series A  and 5 more. Here is the list of top investments by Presight Capital:
Provider of business account, payment cards, and financial management solutions. The company offers tools for customer and supplier invoicing, team expense management, and accounting and bookkeeping. It provides integrations to boost productivity, along with resources such as a resource hub, blog, and finance glossary. The company also provides payment terminals and payment links.

Key facts about Qonto

  • Founded Year: 2017
  • Location: Paris (France)
  • Annual Revenue: €100M - €500M as on Dec 31, 2023
  • Valuation: $*****
  • Stage: Series D
  • Total Funding till date: $717M
  • Employee Count: 2,317 as on Apr 30, 2026
  • Investors: TCV, DST Global and 26 Others
  • Latest Funding Round: Series D, Apr 21, 2022, $*****
  • Highlight: Editors' Pick
AI-enabled platform for antibodies discovery. The company has developed Celium which is an antibody visualization software and suite of proprietary microfluidic single-cell assays used for antibody screening. The company uses its proprietary repertoire sequencing technologies with functional data from single B cells to annotate immune repertoires. It has also developed its proprietary humanized mouse platform for the development of humanized antibodies.

Key facts about Abcellera Biologics

  • Founded Year: 2012
  • Location: Vancouver (Canada)
  • Annual Revenue: $50M - $100M as on Dec 31, 2025
  • Stage: Public
  • Total Funding till date: $115M
  • Employee Count: 589 as on May 31, 2026
  • Investors: HTIF, Benson Family Private Equity and 16 Others
  • Latest Funding Round: Post IPO, Jun 10, 2021, $*****
  • Highlight: Public

3. Syfe

Provider of digital wealth management brokerage and cash savings services. This platform facilitates the management of investment portfolios, the trading of stocks and exchange traded funds, and the allocation of capital into interest bearing savings products. Users access tools for automated asset allocation, rebalancing, and fractional share purchasing across various financial markets. The service enables individuals to maintain diversified holdings and generate passive income through structured investment strategies.

Key facts about Syfe

  • Founded Year: 2017
  • Location: Singapore (Singapore)
  • Annual Revenue: SGD 10M - 50M as on Mar 31, 2025
  • Valuation: $*****
  • Stage: Series C
  • Total Funding till date: $139M
  • Employee Count: 241 as on Mar 31, 2026
  • Investors: Valar Ventures, Presight Capital and 32 Others
  • Latest Funding Round: Series C, Jun 05, 2025, $*****
  • Highlight: Editors' Pick
Unmind is a cloud-based mental health program for employers for improving the mental wellbeing of their employees. The platform provides monitoring and training tools to help in reducing stress,
 enhancing sleep, and improving focus and uses chatbots for increasing user engagement. The company has developed a library of sessions for meditation and mindful exercises, provides evidence-based interventions using the data provided by the employee, and real-time support from a team of experts. Also, the app provides a mood tracking feature for employees to spot patterns and enhance self-awareness. The company provides a dashboard to the employers for monitoring the progress of their workforce.

Key facts about Unmind

Provider of revenue-based financing and business tools for e-commerce businesses. It offers financial products like revenue-based financing, credit cards, and credit lines. The company also provides business tools, including e-commerce analytics and payment solutions. It aims to support the growth of digital-first businesses.

Key facts about Velocity

  • Founded Year: 2020
  • Location: Bengaluru (India)
  • Annual Revenue: ₹10 - ₹50 Cr as on Mar 31, 2025
  • Stage: Series A
  • Total Funding till date: $30.3M
  • Employee Count: 99 as on May 31, 2025
  • Investors: Valar Ventures, FJ Labs and 24 Others
  • Latest Funding Round: Series A, Nov 17, 2021, $*****
  • Highlight: Editors' Pick

Presight Capital's Investments by Stage

Presight Capital has made 16 investments in Seed stage with an average round size of $7.42M, 11 investments in Series A stage with an average round size of $38.4M and 6 investments in Series B stage with an average round size of $68.1M.
Here are Presight Capital's investments by stage:
Stage of entry
No. of Investments
Seed
16
Series A
11
Series B
6
Conventional Debt
1
Series C
1
Others
2
Breakdown of Presight Capital's investments by stage of entrySeed (16)Series A (11)
Note: We have considered here, only first round of investments

Presight Capital's Investments by Sector

Presight Capital has a diverse portfolio, with companies operating in the Enterprise Applications, FinTech, Life Sciences, High Tech and Retail. Notably, it has invested in 32 Tech companies, 27 Enterprise (B2B) companies, 11 Consumer (B2C) companies and at least 8 companies focusing on Software.
Here are Presight Capital's investments by sector:
Sector
No. of Investments
Enterprise Applications
10
FinTech
9
Life Sciences
8
High Tech
7
Retail
6
Others
35
Breakdown of Presight Capital's investments by sectorsEnterprise Applic... (10)FinTech (9)
Note: We have considered here, only first round of investments

Presight Capital's Investments by Geography

Presight Capital has made most investments in United States (12), followed by United Kingdom where it has made 5 investments.
Here are Presight Capital's investments by geography:
Country
No. of Investments
United States
12
United Kingdom
5
India
4
Canada
3
Germany
3
Others
11
Breakdown of Presight Capital's investments by countriesUnited States (12)United Kingdom (5)
Note: We have considered here, only first round of investments

Presight Capital's recent investments

Presight Capital has made 1 investments in 2026 so far - Alloy Therapeutics.
Here are the most recent investments by Presight Capital:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Mar 31, 2026
United States
Series E
7617
  [+8]
Oct 16, 2025
United States
Series B
2281
Sep 10, 2025
United Kingdom
Series A
7319
  [+5]
Aug 22, 2025
Canada
Series F
9787
Aug 05, 2025
United Arab Emirates
Series A
7319

Unicorns in Presight Capital's Portfolio

Presight Capital has 2 unicorns in its portfolio - Qonto and Razor Group. The most recent unicorn in their portfolio is Qonto. It became a unicorn in 2022.
Here is a list of unicorns in Presight Capital's portfolio:
Tracxn Score
Company
Short Description
Founded year
Sector
Location
Company Stage
First Investment/ Acquisition Details
82
Provider of business account, payment cards, and financial management solutions
2017
Paris
Series D
{zedrzp
67
Platform acquiring Amazon FBA brands
2020
Berlin
Series D
{rjvxxa

IPOs and Publicly Listed companies in Presight Capital's Portfolio

2 of Presight Capital's portfolio companies have become public. Sensei Biotherapeutics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Feb 2021 at marketcap of $562M and Abcellera Biologics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $5.31B.
Here are Presight Capital's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Feb 04, 2021
Oct 07, 2020
Unattributed
2828
Dec 11, 2020
Mar 23, 2020
Series B
3014

Acquired companies in Presight Capital's Portfolio

4 companies from Presight Capital's portfolio have been acquired. The most recent acquisition was Denario in Aug 2023 by PandaDoc for $*****.
Here are Presight Capital's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Aug 28, 2023
Jan 10, 2022
Seed
4329
Dec 22, 2022
Feb 16, 2021
Seed
8664
Jul 22, 2022
Jul 07, 2020
Series B
5180
Aug 27, 2018
May 18, 2022
Seed
9833

Team profile of Presight Capital

Presight Capital has a team of 3 members located in United Kingdom. Presight Capital's team does not sit on the board of any company as of now.

Co-investors of Presight Capital

Over the past 7 years, 354 investors have co-invested in Presight Capital's portfolio companies. This includes funds and angels.

  • Invested before Presight CapitalDCVC, Peter Thiel and 105 others have invested in rounds before Presight Capital. There are 2 companies where DCVC has invested before Presight Capital and 2 companies where Peter Thiel has invested before Presight Capital.
  • Top Co-investors of Presight Capital147 investors entered a company along with Presight Capital. These include investors like 468 Capital (10 companies).
  • Invested after Presight CapitalA total of 100 investors have invested in Presight Capital's portfolio after their investments. Top Investors include L Catterton (2 companies), Upper90 (2 companies) and Peter Thiel (2 companies).

Recent News related to Presight Capital

View all news related to Presight Capital

FAQs about Presight Capital

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford